Advertisement
INCY vs PTCT
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INCY is a Buy and PTCT is a StrongBuy.
INCY in upward trend: 10-day moving average broke above 50-day moving average on November 11, 2026
The 10-day moving average for INCY crossed bullishly above the 50-day moving average on November 11, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 79%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where INCY's RSI Oscillator exited the oversold zone, 23 of 34 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on INCY as a result. In 61 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.
The Moving Average Convergence Divergence (MACD) for INCY just turned positive on October 20, 2026. Looking at past instances where INCY's MACD turned positive, the stock continued to rise in 25 of 35 cases over the following month. The odds of a continued upward trend are 71%.
INCY moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where INCY advanced for three days, in 205 of 323 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 151 of 250 cases where INCY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 60%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INCY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
INCY broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 26 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.
The Tickeron SMR rating for this company is 33 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. INCY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 71 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.823) is normal, around the industry mean (3.498). P/E Ratio (14.717) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (10.822) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (4.401) is also within normal values, averaging (440.869).
PTCT in upward trend: price rose above 50-day moving average on November 11, 2026
PTCT moved above its 50-day moving average on November 11, 2026 date and that indicates a change from a downward trend to an upward trend. In 34 of 37 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 03, 2026. You may want to consider a long position or call options on PTCT as a result. In 62 of 83 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.
The Moving Average Convergence Divergence (MACD) for PTCT just turned positive on October 20, 2026. Looking at past instances where PTCT's MACD turned positive, the stock continued to rise in 33 of 43 cases over the following month. The odds of a continued upward trend are 77%.
The 10-day moving average for PTCT crossed bullishly above the 50-day moving average on November 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 14 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +13.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where PTCT advanced for three days, in 217 of 274 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
The Aroon Indicator entered an Uptrend today. In 181 of 228 cases where PTCT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 64 cases where PTCT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 69%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PTCT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
PTCT broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-33.028) is normal, around the industry mean (3.498). PTCT has a moderately low P/E Ratio (-97.672) as compared to the industry average of (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (6.094) is also within normal values, averaging (440.869).
The Tickeron Profit vs. Risk Rating rating for this company is 58 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 69 (best 1 - 100 worst), indicating slightly worse than average price growth. PTCT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
INCY | PTCT | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 24 | 27 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 92 Overvalued | 1 Undervalued | |
PROFIT vs RISK RATING 1..100 | 26 | 58 | |
SMR RATING 1..100 | 33 | 100 | |
PRICE GROWTH RATING 1..100 | 44 | 69 | |
P/E GROWTH RATING 1..100 | 71 | 100 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PTCT's Valuation (1) in the Biotechnology industry is significantly better than the same rating for INCY (92). This means that PTCT’s stock grew significantly faster than INCY’s over the last 12 months.
INCY's Profit vs Risk Rating (26) in the Biotechnology industry is in the same range as PTCT (58). This means that INCY’s stock grew similarly to PTCT’s over the last 12 months.
INCY's SMR Rating (33) in the Biotechnology industry is significantly better than the same rating for PTCT (100). This means that INCY’s stock grew significantly faster than PTCT’s over the last 12 months.
INCY's Price Growth Rating (44) in the Biotechnology industry is in the same range as PTCT (69). This means that INCY’s stock grew similarly to PTCT’s over the last 12 months.
INCY's P/E Growth Rating (71) in the Biotechnology industry is in the same range as PTCT (100). This means that INCY’s stock grew similarly to PTCT’s over the last 12 months.
| INCY | PTCT | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 68% | N/A |
| Stochastic ODDS (%) | 2 days ago 55% | 2 days ago 69% |
| Momentum ODDS (%) | 2 days ago 65% | 2 days ago 75% |
| MACD ODDS (%) | 2 days ago 71% | 2 days ago 77% |
| TrendWeek ODDS (%) | 2 days ago 59% | 2 days ago 77% |
| TrendMonth ODDS (%) | 2 days ago 63% | 2 days ago 78% |
| Advances ODDS (%) | 4 days ago 63% | 9 days ago 79% |
| Declines ODDS (%) | 10 days ago 56% | 3 days ago 79% |
| BollingerBands ODDS (%) | 2 days ago 63% | 2 days ago 73% |
| Aroon ODDS (%) | 2 days ago 60% | 2 days ago 79% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
INCY’s FA Score shows that 2 FA rating(s) are green while PTCT’s FA Score has 1 green FA rating(s).
- INCY’s FA Score: 2 green, 3 red.
- PTCT’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
INCY’s TA Score shows that 7 TA indicator(s) are bullish while PTCT’s TA Score has 6 bullish TA indicator(s).
- INCY’s TA Score: 7 bullish, 3 bearish.
- PTCT’s TA Score: 6 bullish, 3 bearish.
Price Growth
INCY (@Biotechnology) experienced а -0.47% price change this week, while PTCT (@Biotechnology) price change was -5.89% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +11.66%. For the same industry, the average monthly price growth was +1.65%, and the average quarterly price growth was -13.40%.
Reported Earning Dates
INCY is expected to report earnings on Feb 09, 2027.
PTCT is expected to report earnings on Feb 23, 2027.
Industries' Descriptions
@Biotechnology (+11.66% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
INCY and
Correlation & Price change
A.I.dvisor indicates that over the last year, INCY has been loosely correlated with RPRX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if INCY jumps, then RPRX could also see price increases.
| Ticker / NAME | Correlation To INCY | 1D Price Change % | ||
|---|---|---|---|---|
| INCY | 100% | +1.64% | ||
| RPRX - INCY | 49% Loosely correlated | +0.81% | ||
| HALO - INCY | 43% Loosely correlated | -1.26% | ||
| VRTX - INCY | 40% Loosely correlated | -0.16% | ||
| AXON - INCY | 39% Loosely correlated | +4.26% | ||
| PTCT - INCY | 38% Loosely correlated | +1.20% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| AVGG | 20.09 | 1.53 | +8.24% |
| Leverage Shares 2X Long AVGO Daily ETF (AVGG) | |||
| CNEQ | 36.96 | 0.92 | +2.55% |
| Alger Concentrated Equity ETF (CNEQ) | |||
| FINX | 24.63 | 0.36 | +1.48% |
| Global X FinTech ETF (FINX) | |||
| IBMR | 25.20 | 0.01 | +0.04% |
| iShares iBonds Dec 2029 Term Muni Bond ETF (IBMR) | |||
| DIPS | 36.35 | -0.61 | -1.66% |
| YieldMax Short NVDA Option Income Strategy ETF (DIPS) | |||